Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...

The Senate nixed a provision to “delink” drug list prices from compensation for PBMs and other drug middlemen days before its ...

The Chart of the Day What we're watching What we're reading Economic data releases and earnings After the Pelotons (PTON) and Zooms (ZM) of the world enjoyed their glorious time in the pandemic sun, ...

Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...

A new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...

A new weight loss plan that embraces real food, flexibility and freedom is climbing Amazon’s bestseller charts - overtaking ...

A new weight loss plan that embraces real food, flexibility and freedom is climbing Amazon’s bestseller charts - just days after it was featured in the UK’s most-read women’s magazine, Fabulous.

Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

Novo Nordisk's U.S.-listed shares shed a third of their value last week after the company cut its full-year outlook and named ...

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.